Education
About Us
Working with TipRanks
Follow Us
Sino Biopharmaceutical (HK:1177)
:1177
RESEARCH TOOLSreports
Sino Biopharmaceutical (1177) Ownership Overview
10.75% Insiders
2.96%
Mutual Funds
<0.01% Other Institutional Investors
5.52% ETFs
80.76% Public Companies and
Individual Investors
The ownership structure of Sino Biopharmaceutical (HK:1177) stock is a mix of institutional, retail, and individual investors. Approximately 8.48% of the company’s stock is owned by Institutional Investors, 10.75% is owned by Insiders, and 80.76% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jul 16, 2025 | xxxxxxxxxxxxx | HK$6470000 | |
Oct 04, 2024 | xxxxxxxxxxxxx | HK$51359460 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,658,904,241 | Insider | 8.84% | 1,458,176,828 | |
| 391,576,508 | Institution | 2.09% | 344,195,751 | |
| 358,557,270 | Insider | 1.91% | 315,171,840 | |
| 316,681,862 | Institution | 1.69% | 278,363,357 | |
| 150,917,412 | Institution | 0.80% | 132,656,405 | |
| 139,775,818 | Institution | 0.75% | 122,862,944 | |
| 121,597,990 | Institution | 0.65% | 106,884,633 | |
| 100,692,845 | Institution | 0.54% | 88,509,011 | |
| 54,724,750 | Institution | 0.29% | 48,103,055 | |
| 46,363,352 | Institution | 0.25% | 40,753,386 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 150,917,412 | Institution | 0.80% | 132,656,405 | |
| 139,775,818 | Institution | 0.75% | 122,862,944 | |
| 121,597,990 | Institution | 0.65% | 106,884,633 | |
| 46,363,352 | Institution | 0.25% | 40,753,386 | |
| 19,744,936 | Institution | 0.11% | 17,355,799 | |
| 18,269,662 | Institution | 0.10% | 16,059,033 | |
| 15,554,000 | Institution | 0.08% | 13,671,966 | |
| 5,678,071 | Institution | 0.03% | 4,991,024 | |
| 5,171,000 | Institution | 0.03% | 4,545,309 | |
| 4,568,000 | Institution | 0.02% | 4,015,272 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 140,787,818 | Institution | 0.75% | 94,713,935 | |
| 126,601,444 | Institution | 0.67% | 85,170,160 | |
| 95,478,000 | Institution | 0.51% | 83,472,490 | |
| 30,308,500 | Institution | 0.16% | 26,497,475 | |
| 26,145,000 | Institution | 0.14% | 22,857,499 | |
| 24,116,500 | Institution | 0.13% | 20,956,174 | |
| 24,116,500 | Institution | 0.13% | 20,956,174 | |
| 21,521,750 | Institution | 0.11% | 18,815,581 | |
| 20,712,718 | Institution | 0.11% | 13,934,318 | |
| 19,525,000 | Institution | 0.10% | 16,018,054 |
FAQ
Who Owns Sino Biopharmaceutical (HK:1177)?
According to the latest TipRanks data, approximately <0.01% of the company's stock is held by institutional investors, 10.75% is held by insiders, and 80.76% is held by retail investors.
What percentage of Sino Biopharmaceutical (HK:1177) stock is held by institutional investors?
According to the latest TipRanks data, approximately <0.01% of Sino Biopharmaceutical (HK:1177) stock is held by institutional investors.
What percentage of Sino Biopharmaceutical (HK:1177) stock is held by retail investors?
According to the latest TipRanks data, approximately 80.76% of Sino Biopharmaceutical (HK:1177) stock is held by retail investors.
Who owns the most shares of Sino Biopharmaceutical (HK:1177)?
Ping Tse owns the most shares of Sino Biopharmaceutical (HK:1177).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.